Official UK procurement notice
Contracts for the supply of Measles, Mumps and Rubella (MMR) vaccines
Authority: Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency (Central government)
What is being bought
Published requirement descriptionContracts for the supply of Measles, Mumps and Rubella (MMR) vaccines
CPV: Measles-mumps-rubella vaccines
The lotProcurement structure
single lot · no lot value publishedLot #1The provision of a vaccine to protect against measles, mumps and rubella, to be used…Awarded
The provision of a vaccine to protect against measles, mumps and rubella, to be used as part of the national childhood immunisation programme.<br/>Deliveries will be required over a period of 2 years, with an option to extend for up to an additional 24 months.
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
- Comparison with specification: N/A
- Risk to programme delivery: N/A
- Social value: N/A
- Benchmark price: N/A
- Vaccine price: N/A
- Additional costs: N/A
- Additional savings: N/A
- Storage costs: N/A
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- No (one-off requirement)
- First published
- 25 Jan 2023, 12:06 GMT
- Last source update
- 21 Jul 2023, 11:50 BST
- Award evaluation window
- 2 Mar 2023 – …
- Authority reference
CM/PHV/24/125671- FTS notice number
2023/S 000-021083- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-039a78Find a Tender
Publisher note: The contracts are for the benefit of the Authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health related services in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers. The resulting products delivered against the contracts may be made available to the UK devolved administrations, Crown Dependencies and British Overseas Territories to undertake their respective vaccination programmes.<br/><br/>Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the suppliers.
How it was run
Official noticeTender documents are also served through a separate tool: https://health-family.force.com/s/Welcome ↗
- Submission deadline
- 2 Mar 2023, 13:00 GMT
- Submission channel
- {"electronicSubmission","written"}
- Accepted languages
- en
- Bid validity
- 180 days from the deadline
- Bids opened
- 2 Mar 2023, 13:00 GMT
Timeline
2 Mar 2023 → 21 Jul 2023 · 3 dates- Submission deadline2 Mar 2023, 13:00 GMT
- Bids opened2 Mar 2023, 13:00 GMT
- Notice published21 Jul 2023, 11:50 BST
Notice history
1 event · 2 releases on Find a Tender- Status changed to complete21 Jul 2023, 11:50 BST
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| GlaxoSmithKline UK Ltd - Vaccines | £1 † | — | Awarded |
| Merck Sharpe and Dohme (UK) Limited | £1 † | — | Awarded |
Contracts
Contract 021083-2023-1 · GlaxoSmithKline UK Ltd - Vaccines
- Signed
- 17 Jul 2023
- Value
- £1
- Status
- active
Contract 021083-2023-2 · Merck Sharpe and Dohme (UK) Limited
- Signed
- 17 Jul 2023
- Value
- £1
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 2bids · 2 electronic | 0 | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- The High CourtReview body
Bidders & participating suppliers
2 commercial parties on the notice- GlaxoSmithKline UK Ltd - VaccinesAwarded supplier
- MERCK SHARP and DOHME (UK) LIMITEDAwarded supplier
Official documents & specifications (2)
Official links; attachments are not copiedTender pack and attachments
- Economic and financial selection criteria
- Technical selection criteria